Wellgistics Health issues $21M convertible debt, raises $6.5M new capital, refinances all outstanding convertible debt

Wellgistics Health, Inc.

New $21M oversubscribed convertible debt refinances all outstanding convertible debt; no interest; converts at $6.00/share.
Provides $6.5M in new working capital; satisfies closing condition for Datavault AI, Scilex Pharma, and others DelivMeds AI Transaction.
Automatic exchange to Preferred Stock at $50.00/share conversion upon registration effectiveness and shareholder approval (subject to adjustments).
Potential substantial future dilution to existing stockholders upon conversion of the new securities.
Dawson James Securities acted as placement agent for the financing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.